Use of phospholipid derivatives as antiviral pharmaceutical...

C - Chemistry – Metallurgy – 07 – F

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/250, 260/460

C07F 9/09 (2006.01) A61K 31/685 (2006.01) C07F 9/10 (2006.01) C07F 9/165 (2006.01)

Patent

CA 2023944

The present invention is concerned with the use of compounds of the general formula:- Image wherein X is a valency bond, an oxygen or sulphur atom, a sulphinyl, sulphanyl, aminocarbonyl, carbonylamino or ureido group or a C3-C8-cycloalkylene or phenylene radical, Y is an oxygen or sulphur atom, R1 is a hydrogen atom or a straight-chained or branched, saturated or unsaturated alkyl radical containing up to 18 carbon atoms which is optionally substituted one or more times by phenyl, halogen, C1-C4-alkoxy, C1-C4- alkylmercapto, C1-C4-alkoxycarbonyl, C1-C4-alkane- sulphinyl or C1-C4-alkanesulphonyl, R2 is a straight- chained or branched, saturated or unsaturated alkylene chain containing up to 18 carbon atoms which is optionally substituted one or more times by halogen, phenyl, C1-C4-alkoxy, C1-C4-alkoxycarbonyl, C1-C4- alkylmercapto, C1-C4-alkanesulphinyl or C1-C4-alkane- sulphonyl, R3 is a straight-chained or branched, saturated or unsaturated alkylene chain containing 2 to 8 carbon atoms in which one methylene moiety can, be replaced by a C5-C7-cycloalkane ring and which is optionally substituted one or more times by hydroxyl, halogen, nitrile, C5-C7-cycloalkyl, phenyl, C1-C20- alkoxycarbonyl, C1-C20-alkylcarbamoyl, C1-C20-alkyl- mercapto, C1-C20-alkanesulphinyl, C1-C20-alkanesulphonyl or C1-C20-acylamino or by C1-C20-alkoxy which, in turn, can be substituted by phenyl, C1-C20 alkylmercapto, C1-C20-alkanesulphinyl, C1-C20-alkanesulphonyl, C1-C20 acylamino, C1-C20-allcoxycaxbonyl, nitrile, hydroxyl, C1-C20-alkoxy or C1-C20-alkylcarbamoyl, R4 is a straight-chained or branched alkylene chain containing 2 to 4 carbon atoms, R5 is a hydrogen atom or a C1-C6- alkyl radical and the three substituents R5 on the nitrogen atom can be the same or different and n is 0, 1 or 2, and of the pharmacologically acceptable salts thereof, as well as of the optical isomers thereof for their antiviral and antiretroviral action; the invention also provides new phospholipid derivatives within formula (I).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of phospholipid derivatives as antiviral pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of phospholipid derivatives as antiviral pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of phospholipid derivatives as antiviral pharmaceutical... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1978650

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.